L
yn is a Src family tyrosine kinase expressed by hematopoietic cells. It has unique regulatory properties, as it triggers both activation and inhibitory signals (1, 2) . In B lymphocytes, Lyn functions at the initial step of BCR signaling by phosphorylating tyrosines in the ITAMs of the Iga/Igb (CD79a/ CD79b) BCR subunits, initiating signaling events that lead to B cell proliferation and Ab production. However, Lyn is not uniquely required for the initiation of BCR signaling, as the Src family tyrosine kinase members Fyn and Blk compensate for its deficiency (3) . In contrast, Lyn has the sole capability to engage feedback inhibitory pathways by phosphorylating the ITIMs of the sialic acid-binding protein CD22 and the inhibitory Fc receptor for IgG FcgRIIb (4) . Phosphorylation of these ITIM-containing receptors by Lyn leads to the recruitment to the membrane of SHIP-1 and Src homology region 2 domain-containing phosphatase 1 (SHP-1) that inhibit downstream BCR signaling. The function of Lyn in inhibitory signaling is dominant over its role in B cell activation. Hence, Lyn deficiency in B cells leads to enhanced BCR signaling characterized by increased calcium flux, increased activation of the MAPK pathway, and hyperproliferative responses following BCR crosslinking (5, 6) .
Systemic lupus erythematosus (SLE) is a complex autoimmune disease triggered by genetic and environmental factors. It is characterized by a loss of tolerance to nuclear Ags leading to the production of autoreactive Abs, which deposit in tissues as immune complexes causing inflammation and end organ damage. In humans, polymorphisms in the LYN gene have been correlated with lupus disease, and a reduction in LYN expression in B cells has been found in patients with SLE (7, 8) . Lyn 2/2 mice develop an autoimmune inflammatory disease that resembles human lupus. The Lyn-deficient mice have elevated numbers of plasma cells that produce high levels of autoreactive Abs (anti-dsDNA, anti-ssRNA), leading to severe glomerulonephritis (9) (10) (11) (12) . Additionally, the lyn 2/2 mice manifest considerable reduction in the numbers of mature follicular and immature transitional (T1, T2, and T3) B cells in lymphoid organs but equal numbers of newly formed immature B cells in the bone marrow (10, (13) (14) (15) . The reduction in mature B cells in lyn 2/2 mice is thought to be due to defects in survival (increased Bim levels) rather than defects in developmental maturation (6) . Interestingly, the exaggerated BCR signaling associated with Lyn deficiency is predominant in transitional T3 and mature follicular B cell populations, but only moderate in immature T1 and T2 cells. Lyn 2/2 mature follicular B cells display enhanced basal calcium signaling and ERK activation upon BCR engagement (16) . In response, Lyn-deficient transitional B cells and mature follicular B cells exhibit increased expression of CD69, MHC class II (MHC II), and CXCR5 (6) . Lyn 2/2 mice also present defects in germinal center (GC) formation with decreased numbers of GC B cells but accumulation of splenic plasmablasts and autoantibody-producing plasma cells (9) (10) (11) (12) . The autoimmune phenotype of lyn 2/2 mice has been mainly attributed to alterations of B cell function. However, recent findings from our laboratory have shown that lyn 2/2 macrophages and dendritic cells (DCs) also play an important role in the pathogenesis of lupus-like disease in the lyn 2/2 model. Indeed, deletion of Lyn in myeloid cells (using mixed bone marrow chimeric mice) leads to myeloid expansion and the development of an autoimmune phenotype similar to, although not as severe as, the disease in total lyn 2/2 animals (17). Additionally, the specific deletion of Lyn in DCs is sufficient for the spontaneous activation of B and T cells and the subsequent development of autoantibodies and severe nephritis in mice (18 (18) , which we crossed with mice carrying the Cre recombinase under the control of the CD79a/ mb1 promoter (Cd79a-cre) (19) , resulting in deletion of Lyn in B cells. In this study we show that the specific deletion of Lyn in B cells alone is sufficient for the spontaneous activation of B cells, the development of autoreactive Abs, and glomerulonephritis in mice. B cell-specific Lyn-deficient mice exhibited an increase in plasma cell formation as well as a reduction in splenic GCs. The additional deletion of MyD88 in B cells reversed the autoimmune phenotype observed in B cell-specific Lyn-deficient mice by blocking the development of pathogenic IgG autoantibodies. Thus, we demonstrate that the absence of Lyn inhibitory signaling in B cells alone is sufficient to drive autoimmunity.
Materials and Methods

Mice Lyn
2/2 , lyn f/f , myd88 f/f , and Cd79a-cre mice were previously described (18) (19) (20) . All animals were backcrossed at least nine generations onto the C57BL/6 background and kept in a specific pathogen-free facility at the University of California, San Francisco. Animal experiments were done in compliance with the Animal Welfare Act and Regulations, the National Institutes of Health Guide for the Care and Use of Laboratory Animals, the Public Health Service Policy on the Humane Care and Use of Laboratory Animals, and the University of California, San Francisco Policies and Guidelines.
All experiments were done comparing lyn f/f Cd79a-cre
, and C57BL/6 animals to lyn f/f Cd79a-cre Tg/+ (hereafter B-lyn 2/2 ) and lyn 2/2 . The groups lyn f/f Cd79a-cre +/+ , lyn +/+ Cd79a-cre Tg/+ , and C57BL/6 showed similar results (data not shown). For clarity, the data from these three groups were pooled and defined as the control group.
Flow cytometry
Single-cell suspensions were prepared from spleens as previously described (17) , blocked with anti-CD16/32 (clone 2.4G2) and murine IgG (Sigma-Aldrich), and stained with the following: FITC-, R-phycoerythrin-, allophycocyanin-, allophycocyanin-Cy7-or allophycocyanin-Alexa Fluor 780-, PE-Cy7-, or biotin-conjugated Abs; CD11c (clone HL3), CD19 (1D3), CD21 (7G6), CD95/Fas (Jo2), CD117/c-Kit (2B8), CD138 (281-2), GL7 (GL7), Gr-1 (RB6-8C5), IgD b (Igh-5b), Ly6C (AL-21), and MHC II (I-A b , AF6-120.1) from BD Pharmingen; B220 (RA3-6B2), CD4 (RM4-5), CD5 (53-7.3), CD8a (53-6.7), CD11b (M1/70), CD23 (B3B4), CD25 (PC61.5), CD44 (IM7), CD62L (MEL-14), CD86 (GL1), CD93 (AA4.1), IgM (II/41), and TCRb (H57-597) from eBioscience; 7/4 from Abcam; F4/ 80 from Serotec; and IgM Fab from Jackson ImmunoResearch Laboratories. The rabbit polyclonal Ab anti-mouse Lyn was previously described (17) . The gating strategies used to identify the different myeloid, dendritic, and T cell populations by FACS have been previously reported (18) . The gating strategies used to identify B cell populations are shown in Supplemental Fig. 2 . DAPI (0.1 mg/ml; Sigma-Aldrich) staining was used to exclude dead cells.
Flow cytometry data were collected on a Fortessa flow cytometer (Becton Dickinson) from the Flow Cytometry Center at University of California, San Francisco and analyzed using FlowJo software (Tree Star).
Analysis of calcium flux
For measurements of intracellular-free calcium levels, splenocytes were loaded with Indo1-AM (Invitrogen) and then labeled for CD93, CD23, IgM Fab, and B220. Cells were resuspended in RPMI 1640 supplemented with 1% BSA and 20 mM HEPES and warmed to 37˚C for 3 min, and analysis was initiated with flow cytometry. After the baseline was established for 30-45 s, cells were stimulated with 15 mg/ml goat anti-mouse IgM F(ab9) 2 (Jackson ImmunoResearch Laboratories). The median intracellular calcium concentration as indicated by the ratio of fluorescence 405 nm emission to 530 nm emission was measured over time by flow cytometry. Propidium iodide staining was used to exclude dead cells.
Histology
Kidneys were processed and stained with H&E by the University of California, San Francisco Pathology Core. The presence of nephritis was determined on H&E-stained sections. The severities of the disease in the glomerular and interstitial compartments were arbitrarily graded as 0 (absent), 1 (mild), 2 (moderate), or 3 (severe). Morphological analysis of glomerulonephritis involved assessment of glomerular hypercellularity, glomerular size, and presence of glomerular sclerosis. Morphological analysis of interstitial nephritis involved the assessment of infiltration of mononuclear cells and loss of normal architecture. Kidneys were snap frozen in OCT and 5-mm sections were stained for C3 or IgG as previously described (17) .
Quantification of serum Igs, autoantibodies, and cytokines
Serum levels of BAFF, total IgG and IgM, anti-dsDNA IgG and IgM, and anti-Smith Ag ribonucleoprotein (sm/RNP) IgG and IgM were determined by ELISA as previously described (17) . Serum levels of specific IgG isotypes against dsDNA and sm/RNP were determined by ELISA using SouthernBiotech reagents. Cytokine levels in serum were quantified using Milliplex MAP mouse cytokine/chemokine kit from Millipore, following the manufacturer's instructions.
Statistical analyses
Statistical analyses were performed using GraphPad Prism. Statistical differences between three groups or more were calculated with a one-way ANOVA test and a Bonferroni multiple comparison post-hoc test. Only significant differences (p # 0.05) are indicated.
Results
Generation of B cell-specific Lyn-deficient mice
To investigate the specific role of Lyn in B cells, we crossed mice carrying the lyn f/f allele with Cd79a-cre transgenic mice (18, 19) . The efficiency of deletion of the lyn f/f allele by Cre recombination under the control of the Cd79a promoter was determined by intracellular detection of Lyn followed by flow cytometry using peripheral blood leukocytes from 2-mo-old mice (Supplemental Fig. 1 ). In the control mice, Lyn was expressed in B and myeloid cells, but not T cells. Lyn expression in the B cells of lyn f/f Cd79a-cre + mice (B-lyn 2/2 mice hereafter) was reduced to the background levels seen in the total lyn 2/2 animals. We found no reduction in Lyn expression in peripheral blood myeloid cells in B-lyn 2/2 mice, demonstrating the specificity of Lyn deletion in B cells of B-lyn 2/2 mice.
Lyn inhibitory signaling in B cells is required to maintain B cell homeostasis and activation
Previous studies have reported that lyn 2/2 mice exhibit alterations in their B cell compartment that correlate with their autoimmune phenotype (10) (11) (12) 16 ), with a reciprocal reduction in peritoneal B2 cells (Fig. 1F) . The B1 cells in the spleen and peritoneal cavity were CD5 + and therefore were B1a cells (Fig. 1E, 1F ). Interestingly, B-lyn 2/2 mice exhibited high levels of circulating BAFF, similar to those observed in lyn 2/2 animals ( Fig.   1D ), which might contribute to the survival, activation, and differentiation of plasma and B1 cells in B-lyn 2/2 and lyn 2/2 mice. We next characterized by flow cytometry the expression of cell surface MHC II and IgM on the splenic B cells of 8-mo-old B-lyn 2/2 mice, compared with lyn 2/2 and control mice. We found that, similar to
, expression of MHC II was significantly elevated in B-lyn 2/2 B cells, whereas IgM cell surface levels were significantly downregulated ( Fig. 1G, 1H ). These observations likely reflect an enhanced degree of BCR signaling in vivo in both lyn 2/2 and B- To more extensively characterize the effects of Lyn deletion on B cell development, we examined the bone marrow compartment of 2-mo-old lyn 2/2 and B-lyn 2/2 mice. Both total lyn 2/2 and B-lyn
mice exhibited normal percentages of pre-B, pro-B, and immature B cells in the bone marrow ( Fig. 3A ), but they showed significantly decreased numbers of mature recirculating B cells as previously observed (6, 10, 22) . In contrast, splenic B cell development was equivalently reduced in both lyn 2/2 and B-lyn 2/2 mice; both strains manifested progressively reduced numbers of splenic transitional B cells, with T3 cells being the lowest (Fig. 3B-D) . The remaining splenic transitional B cell types all had significantly elevated MHC II expression (Fig. 3E-G ). These results demonstrate that a Lyndependent mechanism, intrinsic to B cells, controls B cell homeostasis and activation. B cells isolated from total lyn 2/2 mice have enhanced signaling responses to BCR engagement (14, 16, 23) . We asked whether the B cells in B-lyn 2/2 mice manifested a similar phenotype by measuring intracellular-free calcium in splenic B cells upon stimulation with 15 mg/ml anti-IgM F(ab9) 2 (Fig. 4) . Similar to lyn mice have increased numbers of activated T cells, which fuels the autoimmune disease via a feedback loop between T and myeloid cells (17, 24, 25) . Specific deletion of Lyn in B cells led to a nonsignificant trend toward increased numbers of effector T cell populations in the spleen (Fig. 5A-C (Fig. 6B, 6C ). The myeloid expansion observed in the B-lyn 2/2 mice resulted in significant splenomegaly and altered architecture of the lymphoid tissues at 8 mo of age, comparable to that observed in the lyn 2/2 mice (Fig. 6D , Supplemental Fig. 3 ).
In lyn 2/2 mice, conventional DCs (cDCs) and plasmacytoid DCs (pDCs) express high levels of the costimulatory molecules CD86 and MHC II, respectively, indicative of their activated state.
In the spleens of 8-mo-old B-lyn 2/2 mice, the numbers of cDCs and pDCs remained unchanged (Fig. 6E, 6G) . However, the Lynsufficient cDCs from B-lyn 2/2 mice expressed high levels of CD86 (Fig. 6F) . Hence, deletion of Lyn in B cells alone is sufficient to induce expansion of the myeloid cell compartments and modest activation of DCs.
Specific deletion of Lyn in B cells results in the development of autoimmunity
To provide a conclusive proof that Lyn deficiency in B cells alone can lead to lupus-like autoimmune disease, B-lyn 2/2 mice were examined for the presence of circulating autoantibodies and tissue immune complexes. Consistent with the presence of exaggerated numbers of plasma cells in the spleens, B-lyn 2/2 mice showed high levels of IgM and IgG isotype anti-sm/RNP and anti-dsDNA autoreactive Abs in the serum, at levels similar to those found in lyn 2/2 animals (Fig. 7A) . As a result, B-lyn 2/2 mice showed enlarged kidney glomeruli, with both IgG and C3 deposition, as well as increased leukocyte infiltration representative of glomerulonephritis (Fig. 7B) . The degrees of IgG and C3 deposition, as well glomerulonephritis, were similar in lyn 2/2 versus B-lyn 2/2 animals (Table I) . Hence, specific deletion of Lyn in B cells alone is sufficient to cause development of immune complex-mediated nephritis in mice.
Cytokines play an important role in the pathogenesis of SLE by stimulating immune cell activation leading to organ damage. We measured the concentration of cytokines in the sera of 6-mo-old B-lyn
, and control mice by Luminex bead array (Fig.  7C) . As previously observed, the lyn 2/2 mice had elevated levels of numerous cytokines such as IFN-g, IL-6, IL-10, IL-17, IL12p40, M-CSF, and GM-CSF (26) . To a lesser extent, similar changes were also observed in the B-lyn 2/2 animals (Fig. 7C) mice exhibited decreased numbers of total and mature B cells, but increased numbers of plasma cells, similar to the B-lyn 2/2 animals ( Fig. 8D-F) . Interestingly, B-lyn 2/2 myd88 2/2 mice still showed high levels of serum BAFF and increased numbers of B1 cells in the peritoneal cavity as observed in the B-lyn 2/2 and lyn 2/2 mice (10 3 10 5 6 1.8 B1 cells, p # 0.001 versus control, p # 0.01 versus lyn 2/2 ). Our observations suggest that elevated BAFF levels might be responsible for the expansion of the B1 compartment (Fig. 8G, 8H ). We then asked whether double mutant mice developed autoimmunity by examining their serum levels of autoreactive Abs and their kidneys for signs of lupus-like disease. Although they showed similar levels of IgM Abs, B-lyn 2/2 myd88 2/2 mice failed to develop pathogenic anti-dsDNA or anti-sm/RNP IgG Abs compared with B-lyn 2/2 mice (Fig. 9A, 9B ). We further investigated the specific IgG subclasses of the autoantibodies in the serum of these mice. In the serum of lyn 2/2 and B-lyn 2/2 mice, IgG autoantibodies (anti-dsDNA and anti-sm/RNP) were mainly of the IgG2b and IgG2c subclasses, which are highly pathogenic (Fig. 9C, 9D ). MyD88 deficiency in B-lyn 2/2 mice resulted in the abrogation of the IgG2b
and IgG2c anti-dsDNA and anti-sm/RNP autoreactive Abs (Fig.  9C, 9D ). In agreement, kidney glomeruli from B-lyn 2/2 myd88 2/2 mice were normal in size and cellularity, and they showed little or no evidence of leukocyte infiltration or C3 or IgG deposition (Fig.  9E) . Thus, the loss of MyD88-dependent signals in Lyn-deficient B cells prevented class switching to pathogenic IgG autoantibodies, reversing the autoimmune phenotype observed in B-lyn 2/2 mice.
Discussion
There is growing recognition that complex interactions between B, T, and DCs underlie the pathogenesis of autoimmune diseases such as SLE (28, 29) . Clearly, this is the case in the Lyn kinase-deficient mouse model. Although many studies have focused on the role of this kinase as a negative regulator in B lymphocytes, it is also a major regulator of innate immune cells, including DCs, neutrophils, and mast cells (2) . To determine whether loss of Lynmediated inhibitory signaling in B cells alone is sufficient to initiate lupus-like autoimmunity, we have used the newly generated lyn f/f mouse to delete Lyn specifically in B cells (18 B1 cells produce most of the serum IgM; expansion of B1 cell numbers and elevated IgM is often associated with autoimmunity (36) . It is thought that BAFF protects B1 cells against FcgRIIbmediated apoptosis and that excessive BAFF levels in mice lead to the expansion of low-affinity self-reactive B cells, including B1 cells, rather than to a dramatic breakdown in B cell tolerance (37) (38) (39) . Interestingly, in the B-lyn 2/2 mice, deficiency of B cell
MyD88 signaling abrogated the production of pathogenic IgG autoreactive Abs, but the B-lyn 2/2 myd88 2/2 mice still produced high levels of IgM self-reactive Abs and high levels of serum BAFF, and they exhibited increased numbers of B1 cells in the peritoneal cavity, suggesting a similar mechanism in lyn 2/2 mice.
This also suggests that the main role of TLR signaling in B cells is to promote class switching of self-reactive clones, which would normally take place in GC B cells. In agreement with this notion, previous studies of mice immunized with nucleic acid-containing virus particles also demonstrated that TLR signaling in B cells can promote the GC response (27) . However, lyn 2/2 animals, whether immunized or not, have altered lymphoid architecture lacking clear follicles and T cell zones, and they exhibit poor splenic GC formation (9, 11, 25, 40, 41 ). These phenotypes were also observed in B-lyn 2/2 mice. The alteration in splenic architecture Kidney inflammation was scored in a blinded fashion as described in Materials and Methods. Briefly, the presence and severities of the disease in the glomerular and interstitial compartments were arbitrarily graded as 0 (absent), 1 (mild), 2 (moderate), or 3 (severe). Data are averaged from at least five microscopic fields per specimen, with five to seven mice (8 mo old) per group. The p values were determined by a one-way ANOVA. , and B-lyn In contrast, in the DC-lyn 2/2 model the primary initiating response is dysregulated MyD88-mediated signaling in DCs probably in response to commensal organisms. This leads to exaggerated proinflammatory cytokine production, which drives T cell activation and production of IFN-g (among other inflammatory cytokines) that in turn feeds back on the DCs to further activate them, leading to a self-amplifying loop of inflammation (17) . This proinflammatory state, which includes high BAFF levels even in the presence of elevated mature B cell numbers, leads to the selection of self-reactive B cell clones producing autoantibodies. The autoantibodies deposit in tissues, which we hypothesize further exacerbates the inflammatory disease. The very proinflammatory nature of the process in the DC-lyn 2/2 mice, with the lymphoproliferation/myeloproliferation, the T cell activation, and the high systemic cytokine production, likely accounts for why the disease is lethal in these mice compared with the B-lyn 2/2 animals. The MyD88 requirement for both the DC-initiated pathway of autoimmune and inflammatory disease and the B cell-initiated lupus-like autoimmunity is consistent with the earlier observation that the autoimmunity of the global lyn 2/2 mice is ablated by crossing to Myd88 2/2 animals (43).
Similar comparisons between B cell-versus DC-specific knockouts of SHP-1 and A20 have recently been reported and reinforce the conclusion that autoimmunity can be initiated by defective negative regulation of receptor signaling in either of these cell types. Deficiency of the tyrosine phosphatase SHP-1 selectively in B cells results in a mild autoimmunity with mild renal immune complex deposition (44) . Lyn phosphorylation of the ITIM of CD22 leads to recruitment of SHP-1, and this is likely a key pathway affected by Lyn deficiency of B cells because the phenotypes resulting from deletion of Lyn or SHP-1 in B cells or deletion of CD22 are all similar (45) . Compared to deletion of SHP-1 in B cells, DCspecific deletion of SHP-1 produces a much more profound inflammatory and autoimmune process, which similar to the DC- animals (47). A20 is a negative regulator of NF-kB pathways downstream of the BCR, TLRs, and a number of other cell types (48) . DC-specific A20-deficient mice, as with DC-specific deletion of Lyn or SHP-1, have a stronger systemic inflammatory and autoimmune disease with rapid end-organ damage (49, 50) . Thus, in all three cases, dysregulation of B cells or DCs can lead to autoimmune and inflammatory disease. Understanding the mechanisms of the cellular interactions in genetic models of autoimmunity is critical for future studies. The approach of cell typespecific deletion of autoimmune susceptibility genes is clearly informative in this regard. These studies illustrate that complex regulatory and counterregulatory networks are operating in the autoimmune Lyn-deficient model. It is very likely that similar processes are present in other autoimmune mice as well as in SLE patients. Indeed, because genome-wide-associated studies have demonstrated that SLE is multigenic and likely genetically diverse among different groups of patients (51) , it is likely that dysregulation of multiple cellular and molecular pathways can predispose to autoimmunity in different individuals, as is the case in mice defective in key negative regulators of receptor signaling such as Lyn, SHP-1, and A20. Therefore, defining which pathways are dysregulated in any given SLE patient will be required to develop appropriate therapy to that patient's disease process. The variable results seen with many current SLE therapies may simply reflect the fact that one cannot treat a heterogeneous disease process with a single agent that affects a single pathway. Thus, disentangling the pathogenic mechanisms in mouse models such as the Lyn-deficient animal may lead to practical improvements in our approach to treating complex autoimmune diseases in humans. 
